Bayer to Turn Over Yaz Documents
We appeared before Judge Herndon in East Saint Louis last week for the first hearing in the Yaz and Yasmin cases. This was the Judge's opportunity to meet some of the Yaz lawyers who have not appeared in his court before and to make sure that the cases are m
oving forward to resolution as quickly and smoothly as is possible given the circumstances.
Before the hearing, Bayer agreed to turn over many of its documents pertaining to the drugs' development and testing. Bayer has told us to expect to receive about a million pages of documents within the next few weeks, and another 30 million pages or more in the months to come.
We expect to begin organizing and analyzing the documents almost immediately upon receiving them. We anticipate that many of the documents will concern drospirenone, the key ingredient in Yaz, Yasmin and Ocella. We will be searching the documents for evidence of what Bayer knew about the dangers of drospirenone and when.
Next hearing before Judge Herndon: December 17.